Egyptian Council for Health Affairs
Non-for-profit Cairo-based legal entity licensed since 2003 under the Laws of Egyptian Government. Recognized scope of activities covers all territory of Egypt, but authorized to cooperate with all other Governments and International organizations. Members mount up to 480 of society leaders, policy and decisions makers including top eminent professors of Medicine, Pharmacology, Law, Economics, Management, and distinguished public opinion leaders and media professionals. Its aims include Empowerment of all stakeholders of health services providers, related medicine and pharmacology scientific societies’ partners, and public welfare recipients and donors to bridge the cultural gap between them and the internationally advanced standards. Health sector reform
ECHA is following the various initiatives and programs of Organizational and individual capacity building of the entities governing the pharmaceutical sector in Egypt:
Central Administration of Pharmaceutical Affairs- CAPA
National Organization of Drug Control & Research – NODCAR
Center of Pharmaceutical Policy Planning – CPPP
National Organization of Biological Control & Research – NOBCAR
Technical and organizational capacity building in areas of API and raw materials manufacturing and trading
QA, GMP, and auditing systems
Inspection and Assessment of drug effects
Drug code of ethics in Egypt
Dispensing procedures and application problems
Drugs registration, pricing, and licensing. Scientific research procedures in drug sector
Pharmaceutical reform:
I, E, and C (Information, Education, and Communication) for Government Agencies, manufacturers, traders, pharmacists, doctors and patients through T.V., magazines, brochures, etc. Allying with parallel International agencies like FDA, WHO, CE, etc. and adopting field and academic studies about pharmaceuticals pricing, handling, and storage
